Stable thrombin composition

(19)

(11)

EP 1 649 867 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	08.09.2021 Bulletin 2021/36

(45)	Mention of the grant of the patent:
	25.11.2020 Bulletin 2020/48

(21)	Application number: 05380229.4

(22)	Date of filing: 17.10.2005

(51)

International Patent Classification (IPC):

A61K 38/48^(2006.01)
C12N 9/74^(2006.01)

A61K 9/19^(2006.01)

(54)	Stable thrombin composition Stabile Thrombin-Zusammensetzungen Compositions de thrombine stables

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

22.10.2004 ES 200402523

(43)	Date of publication of application:
	26.04.2006 Bulletin 2006/17

(73)	Proprietor: Grifols, S.A.
	08022 Barcelona (ES)

(72)	Inventors:
	Jorquera Nieto, Juan Ignacio 08480 Ametlla del Valles (Barcelona) (ES) Ristol Debart, Pere 08203 Sabadell (Barcelona) (ES) Fernandez Rodriguez, Jesus 08850 Gava (Barcelona) (ES) Bravo Camison, Isabel 08240 Manresa (Barcelona) (ES) Lopez Gomez, Rafael 08013 Barcelona (ES)

(74)	Representative: Durán Moya, Luis-Alfonso et al
	DURAN-CORRETJER Còrsega, 329 (Paseo de Gracia/Diagonal) 08037 Barcelona 08037 Barcelona (ES)

(56)

References cited: :

EP-A- 0 444 692
WO-A-99/23111
US-A- 5 304 372

EP-A- 1 221 479
US-A- 4 923 815
US-A- 5 506 127

PATENT ABSTRACTS OF JAPAN vol. 005, no. 098 (C-060), 25 June 1981 (1981-06-25) & JP 56 039782 A (DAI ICHI PURE CHEM CO LTD), 15 April 1981 (1981-04-15)
ANONYMOUS: "THROMBOSTAT" INTERNET ARTICLE, [Online] 28 October 2001 (2001-10-28), XP002369173 Retrieved from the Internet: URL:https://www.eknowhow.com/ekh_drugdatab ase/html/default.asp?> [retrieved on 2006-02-21]
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; December 2000 (2000-12), ELOMBO FERDINAND KOUOH ET AL: "Purification of human ceruloplasmin as a by-product of C1-inhibitor", Database accession no. PREV200100147421 & BIOLOGICAL AND PHARMACEUTICAL BULLETIN, vol. 23, no. 12, December 2000 (2000-12), pages 1406-1409, ISSN: 0918-6158

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).